We report transcriptional response to ribociclib treatment in resistant and sensitive CAMA-1 cells using RNA sequencing. Acquired ribociclib resistant cells were generated by treating CAMA-1 cells over a period of 5 month. Cells were then treated with ribociclib or DMSO control and processed for RNA sequencing. SOURCE: Jeffrey Chang (jeffrey.t.chang@uth.tmc.edu) -  UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON

Pluto Bioinformatics

GSE143944: Transcriptional profiling of ribociclib-treated sensitive and ribociclib resistant CAMA-1 cells